Barcelona, Spain: The Clinical Trials Directive, which came into force in May 2004 in order to create a harmonised framework for clinical drug research across Europe, is still hampering such research, according to new findings presented at the European Cancer Conference (ECCO 14) today (Thursday 27 September 2007). Dr. Markus Hartmann, from European Consulting and Contracting in Oncology, Trier, Germany, said that his findings confirm other observations reporting a decrease in cancer clinical trials since the introduction of the Directive, and that this was likely to turn Europe into the poor relation of clinical academic medicine.
